146 related articles for article (PubMed ID: 35271462)
21. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
22. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma.
Xie H; Shi M; Liu Y; Cheng C; Song L; Ding Z; Jin H; Cui X; Wang Y; Yao D; Wang P; Yao M; Zhang H
Front Immunol; 2022; 13():914977. PubMed ID: 36032107
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
24. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
26. IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.
Lu Z; Yang H; Shao Y; Sun W; Jiang Y; Li J
Biochem Biophys Res Commun; 2022 Oct; 627():103-110. PubMed ID: 36030651
[TBL] [Abstract][Full Text] [Related]
27. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
28. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
29. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
Zhou J; Wang X; Li Z; Jiang R
FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
[TBL] [Abstract][Full Text] [Related]
30. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.
Dai T; Li J; Lu X; Ye L; Yu H; Zhang L; Deng M; Zhu S; Liu W; Wang G; Yang Y
Pharmgenomics Pers Med; 2021; 14():927-945. PubMed ID: 34377010
[TBL] [Abstract][Full Text] [Related]
32. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
Wu X; Liu C; Li Z; Gai C; Ding D; Chen W; Hao F; Li W
Mol Cell Biochem; 2020 Oct; 473(1-2):217-228. PubMed ID: 32642794
[TBL] [Abstract][Full Text] [Related]
33. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
34. A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma.
Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
Aging (Albany NY); 2021 Nov; 13(22):24866-24881. PubMed ID: 34839280
[TBL] [Abstract][Full Text] [Related]
35. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450.
Zhang L; Yang L; Du K
J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
37. Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma.
Fang C; Liu S; Feng K; Huang C; Zhang Y; Wang J; Lin H; Wang J; Zhong C
Sci Rep; 2022 Apr; 12(1):6642. PubMed ID: 35459272
[TBL] [Abstract][Full Text] [Related]
38. BICD1 functions as a prognostic biomarker and promotes hepatocellular carcinoma progression.
Jiang Y; Yao B; Chen T; Mo H; Chen S; Liu Q; Sun Y
Pathol Res Pract; 2020 Apr; 216(4):152858. PubMed ID: 32088084
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma.
Zhang Y; Ren H; Zhang C; Li H; Guo Q; Xu H; Cui L
Front Immunol; 2022; 13():1028054. PubMed ID: 36304446
[TBL] [Abstract][Full Text] [Related]
40. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
